Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for decrease (increase) in trade and other receivables |
1,554,000
USD
|
1,873,000
USD
|
| Adjustments for increase (decrease) in trade and other payables |
2,011,000
USD
|
3,256,000
USD
|
| Adjustments for decrease (increase) in other current assets |
1,821,000
USD
|
1,196,000
USD
|
| Adjustments for decrease (increase) in biological assets |
12,209,000
USD
|
1,933,000
USD
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
243,000
USD
|
2,301,000
USD
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
14,095,000
USD
|
95,000
USD
|